Brookline Capital Markets Starts Oncternal Therapeutics (ONCT) at Buy

March 30, 2021 8:44 AM EDT
Get Alerts ONCT Hot Sheet
Price: $5.27 --0%

Rating Summary:
    4 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 15 | Down: 13 | New: 24
Trade Now! 
Join SI Premium – FREE

Brookline Capital Markets initiates coverage on Oncternal Therapeutics (NASDAQ: ONCT) with a Buy rating and a price target of $16.00.

For an analyst ratings summary and ratings history on Oncternal Therapeutics click here. For more ratings news on Oncternal Therapeutics click here.

Shares of Oncternal Therapeutics closed at $7.58 yesterday.

You May Also Be Interested In

Related Categories

New Coverage